Android Apple

Healthy Returns: Wall Street mulls over Amgen's weight loss drug data

By CNBC   |   2 weeks ago
Healthy Returns: Wall Street mulls over Amgen's weight loss drug data

Amgen's experimental weight loss injection, MariTide, showed promising results with up to 20% weight loss in patients. Analysts note concerns about efficacy and tolerability. Amgen aims to compete in the obesity and diabetes market with a convenient dosing schedule.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.